Literature DB >> 1092791

Effects on C-reactive protein on the lymphoid system. I. Binding to thymus-dependent lymphocytes and alteration of their functions.

R F Mortensen, A P Osmand, H Gewurz.   

Abstract

C-reactive protein (CRP) is an acute phase protein which shares with the immunoglobulins the ability to induce precipitation and agglutination reactions and activate the complement system. We report here that purified human CRP binds selectively to human T lymphocytes, inhibits their ability to form spontaneous rosettes with sheep erythrocytes and inhibits their response to allogeneic cells in mixed lymphocyte culture reactions; it fails to inhibit phytohemagglutinin- or concanavalin-A-induced mitogenesis. CRP does not bind to human B lymphocytes, nor does it alter the following B-cell functions: binding to activated complement components or the Fc portion of immunoglobulins, mediation of antibody-dependent cytotoxicity reactions or the ability of allogeneic cells to stimulate a mixed lymphocyte culture reaction. Human CRP shows similar selective binding with murine T lymphocytes. It therefore seems that binding of CRP is a property of T lymphocytes or a subpopulation thereof, and can result in modulation of certain of the T-cell functional characteristics in vitro. We suggest that CRP may play a role in modulating T-cell functions during the inflammatory state.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1092791      PMCID: PMC2189740     

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  51 in total

1.  Inhibition of the mixed lymphocyte reaction by antibodies.

Authors:  J P Revillard; M Robert; H Betuel; M Latour; M Bonneau; J Brochier; J Traeger
Journal:  Transplant Proc       Date:  1972-06       Impact factor: 1.066

2.  Blocking of autologous and homologous leukocyte responses by human alloimmune plasmas: a possible in vitro correlate of enhancement.

Authors:  R H Buckley; R I Schiff; D B Amos
Journal:  J Immunol       Date:  1972-01       Impact factor: 5.422

3.  Immunoglobulin peptide with complement fixing activity.

Authors:  J M Kehoe; M Fougereau
Journal:  Nature       Date:  1969-12-20       Impact factor: 49.962

4.  Thymus dependence of theta-bearing cells in the peripheral lymphoid tissues of mice.

Authors:  M C Raff; H H Wortis
Journal:  Immunology       Date:  1970-06       Impact factor: 7.397

5.  C-reactive protein: a molecule composed of subunits.

Authors:  E C Gotschlich; G M Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1965-08       Impact factor: 11.205

6.  Estimation of the molecular size of C-reactive protein and CX-reactive protein in serum.

Authors:  I Kushner; J A Somerville
Journal:  Biochim Biophys Acta       Date:  1970-04-28

7.  Immediate hypersensitivity responses in flatfish.

Authors:  T C Fletcher; B A Baldo
Journal:  Science       Date:  1974-07-26       Impact factor: 47.728

8.  Association of C-reactive protein and circulating leukocytes with resistance to Staphylococcus aureus infection in endotoxin-treated mice and rabbits.

Authors:  L T Patterson; J M Harper; R D Higginbotham
Journal:  J Bacteriol       Date:  1968-04       Impact factor: 3.490

9.  The occurrence during acute infections of a protein not normally present in the blood. V. Physical-chemical properties of the C-reactive protein crystallized by a modified technique.

Authors:  H F WOOD; M McCARTY; R J SLATER
Journal:  J Exp Med       Date:  1954-07-01       Impact factor: 14.307

10.  Studies of the human lymphocyte receptor for heat-aggregated or antigen-complexed immunoglobulin.

Authors:  H B Dickler
Journal:  J Exp Med       Date:  1974-08-01       Impact factor: 14.307

View more
  37 in total

1.  Interactions of alpha1-acid glycoprotein with the immune system. I. Purification and effects upon lymphocyte responsiveness.

Authors:  K M Chiu; R F Mortensen; A P Osmand; H Gewurz
Journal:  Immunology       Date:  1977-06       Impact factor: 7.397

2.  E-rosette inhibiting substance in Hodgkin's disease spleen extracts.

Authors:  M M Bieber; Z Fuks; H S Kaplan
Journal:  Clin Exp Immunol       Date:  1977-09       Impact factor: 4.330

3.  C-reactive protein in childhood meningitides.

Authors:  H K Pemde; K Harish; Y P Thawrani; S Shrivastava; K M Belapurkar
Journal:  Indian J Pediatr       Date:  1996 Jan-Feb       Impact factor: 1.967

4.  Inhibition of lymphocyte proliferation stimulated by lectins and allogeneic cells by normal plasma lipoproteins.

Authors:  J H Morse; L D Witte; D S Goodman
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

5.  Clinical significance of immunopathological findings in patients with post-pericardiotomy syndrome. II. The significance of serum inhibition and rosette inhibitory factors.

Authors:  B Maisch; P Schuff-Werner; P A Berg; K Kochsiek
Journal:  Clin Exp Immunol       Date:  1979-11       Impact factor: 4.330

6.  Host defense against the pneumococcus in T-lymphocyte-deficient, nude mice.

Authors:  J A Winkelstein; A J Swift
Journal:  Infect Immun       Date:  1975-11       Impact factor: 3.441

7.  Characterization of C-reactive protein and the complement subcomponent C1t as homologous proteins displaying cyclic pentameric symmetry (pentraxins).

Authors:  A P Osmand; B Friedenson; H Gewurz; R H Painter; T Hofmann; E Shelton
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

8.  Acute phase proteins, C9, factor B, and lysozyme in recurrent oral ulceration and Behçet's syndrome.

Authors:  T Lehner; M Adinolfi
Journal:  J Clin Pathol       Date:  1980-03       Impact factor: 3.411

9.  C-reactive protein directly suppresses Th1 cell differentiation and alleviates experimental autoimmune encephalomyelitis.

Authors:  Lin Zhang; Shan-Hui Liu; Tyler T Wright; Zhi-Yuan Shen; Hai-Yun Li; Wei Zhu; Lawrence A Potempa; Shang-Rong Ji; Alexander J Szalai; Yi Wu
Journal:  J Immunol       Date:  2015-04-27       Impact factor: 5.422

10.  Lymphocytes binding C-reactive protein during acute rheumatic fever.

Authors:  R C Williams; K A Kilpatrick; M Kassaby; Z H Abdin
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.